Literature DB >> 23219623

Periacetabular bone mineral density changes after resurfacing hip arthroplasty versus conventional total hip arthroplasty. A randomized controlled DEXA study.

José M H Smolders1, Dean F Pakvis, Baudewijn W Hendrickx, Nico Verdonschot, Job L C van Susante.   

Abstract

A randomized controlled trial was performed to evaluate acetabular bone mineral density (BMD) changes after hip resurfacing (RHA) versus an established conventional total hip arthroplasty (THA). A total of 71 patients were allocated randomly to receive either an RHA press-fit cobalt-chromium cup (n=38) or a THA with a threaded titanium cup and polyethylene-metal-inlay insert (n=33). The BMD in five separate periacetabular regions of interest (ROI) was prospectively quantified preoperative until 24 months. We conclude that, in contrast to our hypothesis, periacetabular BMD was better preserved after RHA than after placement of a conventional THA. Long term follow-up studies are necessary to see whether this benefit in bone preservation sustains over longer time periods and whether it is turned into clinical benefits at future revision surgery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone mineral density; hip arthroplasty; metal-on-metal; resurfacing hip arthroplasty; threaded acetabular component

Mesh:

Substances:

Year:  2012        PMID: 23219623     DOI: 10.1016/j.arth.2012.08.025

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

Review 1.  Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature.

Authors:  Peter D H Wall; Bethan L Richards; Andrew Sprowson; Rachelle Buchbinder; Jasvinder A Singh
Journal:  Syst Rev       Date:  2017-05-30

2.  Bone mineral density changes in the graft after acetabular impaction bone grafting in primary and revision hip surgery.

Authors:  Davey M J M Gerhardt; Enrico De Visser; Baudewijn W Hendrickx; Berend W Schreurs; Job L C Van Susante
Journal:  Acta Orthop       Date:  2018-04-11       Impact factor: 3.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.